Clinical experience with antagonist-induced opiate withdrawal under anaesthesia
- PMID: 9624727
- DOI: 10.1046/j.1360-0443.1998.93226910.x
Clinical experience with antagonist-induced opiate withdrawal under anaesthesia
Abstract
Aims: The study describes experience with antagonist-induced opiate withdrawal under anaesthesia in standard clinical conditions.
Design: The study was restricted to patients who had undergone failed withdrawal treatments with usual methods over the past months. No control group was used. SETTING AND PROCEDURE: The patients were selected after history-taking and examination. A multi-axial diagnosis was performed. They were then admitted to an inpatient treatment unit for addicted patients. On the second day they were put into neurological intensive care. There they were intubated, ventilated and anaesthetized with propofol for 6 hours. Shortly after induction of anaesthesia, naloxone and naltrexone were administered. A high amount of fluid was used to balance changes in water and electrolytes. After anaesthesia the patients were transferred back to the addiction ward and sedated with clonidine. The patients were then fully mobilized. On discharge 50 mg naltrexone were given daily.
Participants: Eighty-eight patients were treated. They were long-term opiate users. Preference was given to methadone-substituted patients who were unable to rid themselves of methadone.
Measurements: The account given is based solely on clinical observations.
Findings: The first 14 patients were observed in detail and it is on them that this report is based. It was found that withdrawal from codeine and methadone can be shortened to approximately 2-3 days. No patient was in a condition to go home immediately after anaesthesia. Twelve patients showed significant symptoms on the day following anaesthesia. The majority of patients treated by this method will continue to suffer withdrawal symptoms for a few days after detoxification, after which time most can be treated in an outpatient setting. Dysfunction of the cardiovascular system, the lungs, the kidneys or other organs was not observed. Taking into account all the 88 patients, five had to stay in hospital for a longer period (up to 2 weeks) because of a prolonged withdrawal syndrome.
Similar articles
-
Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.Acta Anaesthesiol Scand. 2000 Mar;44(3):326-33. doi: 10.1034/j.1399-6576.2000.440319.x. Acta Anaesthesiol Scand. 2000. PMID: 10714849
-
Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns.Crit Care Med. 2000 Apr;28(4):969-76. doi: 10.1097/00003246-200004000-00010. Crit Care Med. 2000. PMID: 10809268 Clinical Trial.
-
Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification.Pharmacopsychiatry. 1998 Nov;31(6):205-9. doi: 10.1055/s-2007-979329. Pharmacopsychiatry. 1998. PMID: 9930633 Clinical Trial.
-
[Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol].Encephale. 2001 Mar-Apr;27(2):187-93. Encephale. 2001. PMID: 11407272 Review. French.
-
[Limited role of naltrexone in the treatment of opiate addiction].Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1452-6. Ned Tijdschr Geneeskd. 2001. PMID: 11503313 Review. Dutch.
Cited by
-
Potential uses of naltrexone in emergency department patients with opioid use disorder.Clin Toxicol (Phila). 2019 Sep;57(9):753-759. doi: 10.1080/15563650.2019.1583342. Epub 2019 Mar 4. Clin Toxicol (Phila). 2019. PMID: 30831039 Free PMC article. Review.
-
Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD002022. doi: 10.1002/14651858.CD002022.pub3. Cochrane Database Syst Rev. 2010. PMID: 20091529 Free PMC article.
-
Agonist-antagonist combinations in opioid dependence: a translational approach.Dipend Patologiche. 2010;5(1):17-24. Dipend Patologiche. 2010. PMID: 22448305 Free PMC article.
-
Ultrarapid opioid detoxification: current status in iran and controversies.Int J High Risk Behav Addict. 2013 Dec;2(3):96-9. doi: 10.5812/ijhrba.13140. Epub 2013 Dec 12. Int J High Risk Behav Addict. 2013. PMID: 24971284 Free PMC article. No abstract available.
-
Six-month follow-up study of ultrarapid opiate detoxification with naltrexone.Int J High Risk Behav Addict. 2014 Sep 17;3(4):e20944. doi: 10.5812/ijhrba.20944. eCollection 2014 Dec. Int J High Risk Behav Addict. 2014. PMID: 25741479 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous